EX-10.2










Exhibit 10.2 




NON-QUALIFIED
STOCK OPTION AGREEMENT



        THIS
AGREEMENT is made as of October 29, 2004 between AngioDynamics, Inc.
(“Angio”) and ___________________ (“Optionee”). Terms
used herein have the same meaning as in Angio’s Spin-Off Adjustment Stock Option Plan
for Certain Participants in the E-Z-EM, Inc. 1984 Directors and Consultants Stock Option
Plan (“Plan”) unless otherwise defined herein. 



	 	1. 	Angio
hereby grants to Optionee a Non-Qualified Stock Option to purchase ______ Shares of Angio
Common Stock pursuant and subject to the terms of the Plan (the “Option”).  A
copy of the Plan has                      been delivered to Optionee and is incorporated
herein by reference.  The Option is being granted as one of the Spin-Off adjustments to
the stock options that were granted to the                      Optionee under the
E-Z-EM, Inc. (“EZM”) 1984 Directors and Consultants Stock Option Plan on ______
and that had not terminated, expired or been exercised on or before the
                     October 11, 2004 record date of the Spin-Off.






	 	2. 	The
option price per share shall be $____________.  Subject to Section 8(c) of the Plan, the
option price may be paid in cash or by surrendering Angio Shares that the Optionee has
owned for at                      least six months or acquired on the open market.






	 	3. 	The
Option shall expire, unless earlier terminated pursuant to other provisions of this
Agreement, with respect to the number of Shares stated in Section 1 above, as follows:
 __% on                      ________________ and __% on __________________.






	 	4. 	In
the event Optionee becomes employed by, associated in any way with, or the beneficial
owner of more than 1% of the equity of any business which competes, directly or
indirectly, with Angio’s                      business or the business of EZM in any
geographical area where Angio or EZM then does business, the Option shall immediately
expire and Optionee shall have no rights hereunder. In no                      event
shall EZM be deemed to compete with Angio nor shall Angio be deemed to compete with EZM
within the meaning of this Section 4.






	 	5. 	Except
as provided in Section 3, 4, 7 or 8, the Option shall become fully exercisable on
_______________________.






	 	6. 	The
Option shall not be transferable otherwise than by will or by the laws of descent and
distribution and during the lifetime of Optionee shall be exercisable only by Optionee. 






	 	7. 	In
the event Optionee ceases to be a member of the Board of Directors of or a consultant to
EZM for any reason other than death or disability, the Option may be exercised (if it has
not expired                      or terminated under Sections 3 or 4 and is exercisable
under Section 5) only during the period ending three months from the date of such
cessation.  If the Optionee is a member of the                      Board of Directors of
Angio on the October 11, 2004 record date of the Spin-Off, then the Optionee’s
continued service as a director of Angio after the Spin-Off shall be treated as
                     service as a member of the Board of Directors of EZM within the
meaning and solely for purposes of this Section 7 and Section 8 below.






	 	8. 	In
the event Optionee ceases to be a member of the Board of Directors of or consultant to
EZM by reason of death or disability, the Option may be fully exercised as to all Shares
covered hereby                      (if it has not expired or terminated under Sections 3
or 4 but regardless of whether it is exercisable under Section 5) only during the period
ending six months from the date of such                      cessation.






	 	9. 	Nothing
herein or in the Plan shall confer upon any director or consultant of EZM or Angio any
right to continue as a member of the Board of Directors or otherwise in the service of
EZM or                      Angio.






	 	10. 	The
Option and the Plan are subject to adjustments, modifications and amendments as provided
in the Plan.






6 




 






	 	11. 	Subject
to the Plan, this Agreement shall bind and inure to the benefit of Angio, EZM, Optionee
and their respective successors, assigns and personal representatives. 






	 	12. 	This
Agreement will be governed by and construed under the laws of Delaware.






	 	13. 	Any
disputes, claims or interpretive issues arising hereunder shall be resolved by the
Committee in its sole and absolute discretion, and the Committee’s determinations
shall be final and                      uncontestable.






        IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective from the
date first above written. 



			ANGIODYNAMICS, INC.



By: ___________________________________



By: ___________________________________ 






7